Updates are available Erratum dated 2021-07-01
Click to view Erratum: https://doi.org/10.1007/s13311-021-01120-8
-
Authors
Rudnicki, Stacy A.
Andrews, Jinsy A.
Duong, Tina
Cockroft, Bettina M.
Malik, Fady I.
Meng, Lisa
Wei, Jenny
Wolff, Andrew A.
Genge, Angela
Johnson, Nicholas E.
Tesi-Rocha, Carolina
Connolly, Anne M.
Darras, Basil T.
Felice, Kevin
Finkel, Richard S.
Shieh, Perry B.
Mah, Jean K.
Statland, Jeffrey
Campbell, Craig
Habib, Ali A.
Kuntz, Nancy L.
Oskoui, Maryam
Day, John W. http://orcid.org/0000-0002-0086-9529
-
Funding
Funding for this research was provided by:
Cytokinetics Incorporated (N/A)
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-01004-3
CrossRef DOI link to the associated document: https://doi.org/10.1007/s13311-021-01120-8
Content Type: article
Copyright: Copyright © 2021 The authors. Published by Elsevier B.V. All rights reserved.
